Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 2/20 | 0.47 |
| ▸ | GSK3B | P49841 | 3/20 | 0.44 |
| ▸ | ACE | P12821 | 3/20 | 0.43 |
| ▸ | MME | P08473 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | CCKBR | P32239 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10509805 | 0.91 | ACE (0.47) | GSK3BACEMME | |
| SCHEMBL10858951 | 0.89 | ACE (0.43) | ACEMME | |
| SCHEMBL10512983 | 0.88 | SMN1; SMN2 (0.47) | GSK3BACEMMETP53THRB | |
| SCHEMBL10512122 | 0.86 | GSK3B (0.41) | PDPK1GSK3BACEMMETP53 | |
| SCHEMBL10509753 | 0.86 | ALOX15 (0.50) | PDPK1GSK3BALOX15HSD17B10TP53 | |
| SCHEMBL7281552 | 0.83 | CYP3A4 (0.45) | GSK3BACEMMETHRBCACNA1C | |
| SCHEMBL10510913 | 0.82 | ACE (0.45) | PDPK1GSK3BACEMME | |
| SCHEMBL10879320 | 0.79 | TSHR (0.44) | PDPK1GSK3BALOX15HSD17B10MAPT | |
| SCHEMBL7291421 | 0.78 | CYP2C19 (0.41) | CACNA1C | |
| SCHEMBL10508518 | 0.78 | ACE (0.43) | ACEMMETP53CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0162776-B1 | HETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS USEFUL AS ALDOSE REDUCTASE INHIBITORS CONTAINING THEM | LABORATOIRES UPSA (FR) | 1989-04-19 | — | — | EP | disclosed |
| EP-0162776-A2 | Heterocyclic derivatives, process for their preparation and medicaments useful as aldose reductase inhibitors containing them | LABORATOIRES UPSA (FR) | 1985-11-27 | — | — | EP | disclosed |